Literature DB >> 16645512

Temporal and geographic trends of rotavirus activity in the United States, 1997-2004.

Reina M Turcios1, Aaron T Curns, Robert C Holman, Indra Pandya-Smith, Ashley LaMonte, Joseph S Bresee, Roger I Glass.   

Abstract

Rotavirus (RV) has a characteristic seasonal pattern in the 48 contiguous states of the continental United States, and climatologic factors have been implicated though not confirmed. Since 1997, three significant events occurred, including strong El Niño and La Niña climatologic phenomena, and the brief introduction of a rotavirus (RV) vaccine. We examined trends in RV activity in the continental United States between 1997 and 2004, using data from a network of over 70 laboratories that voluntarily report weekly RV detection rates within the National Respiratory and Enteric Virus Surveillance System (NREVSS). Analysis of NREVSS data indicates characteristic winter activity that begins in the Southwest in December or January, moves across the country, and ends in the Northeast in April or May. This pattern was not affected by the brief use of RV vaccine nor by periods of climate change associated with the El Niño and La Niña phenomena. The temporal and geographic pattern of RV spread in the United States has persisted since its initial description and defies easy explanation. An impact of the RV vaccine was not observed, either because of the limited uptake of the vaccine or the inherent variability of the system. NRVESS permits a gross assessment of RV geographic and temporal trends in the United States, but underscores the need for additional assessment mechanisms.

Mesh:

Year:  2006        PMID: 16645512     DOI: 10.1097/01.inf.0000214987.67522.78

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

Review 1.  [Epidemiology of infectious acute diarrhoea in France and Europe].

Authors:  S Alain; F Denis
Journal:  Arch Pediatr       Date:  2007-10       Impact factor: 1.180

2.  Major Changes in Spatiotemporal Trends of US Rotavirus Laboratory Detections After Rotavirus Vaccine Introduction-2009-2021.

Authors:  Eleanor Burnett; Umesh D Parashar; Amber Winn; Aaron T Curns; Jacqueline E Tate
Journal:  Pediatr Infect Dis J       Date:  2022-06-01       Impact factor: 3.806

3.  Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics.

Authors:  Virginia E Pitzer; Cécile Viboud; Lone Simonsen; Claudia Steiner; Catherine A Panozzo; Wladimir J Alonso; Mark A Miller; Roger I Glass; John W Glasser; Umesh D Parashar; Bryan T Grenfell
Journal:  Science       Date:  2009-07-17       Impact factor: 47.728

Review 4.  Rotavirus vaccines: an overview.

Authors:  Penelope H Dennehy
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

5.  Treatment and prevention of rotavirus infection in children.

Authors:  Penelope H Dennehy
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

6.  Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh.

Authors:  Mustafizur Rahman; Rasheda Sultana; Giasuddin Ahmed; Sharifun Nahar; Zahid M Hassan; Farjana Saiada; Goutam Podder; Abu S G Faruque; A K Siddique; David A Sack; Jelle Matthijnssens; Marc Van Ranst; Tasnim Azim
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

Review 7.  Rotaviruses: from pathogenesis to vaccination.

Authors:  Harry B Greenberg; Mary K Estes
Journal:  Gastroenterology       Date:  2009-05-07       Impact factor: 22.682

8.  Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5).

Authors:  Robbin Itzler; Gary Koch; David O Matson; Leif Gothefors; Pierre Van Damme; Mark J Dinubile; Penny M Heaton
Journal:  BMC Pediatr       Date:  2010-06-11       Impact factor: 2.125

9.  Tracking the spatial diffusion of influenza and norovirus using telehealth data: a spatiotemporal analysis of syndromic data.

Authors:  Duncan L Cooper; Gillian E Smith; Martyn Regan; Shirley Large; Peter P Groenewegen
Journal:  BMC Med       Date:  2008-06-26       Impact factor: 8.775

10.  Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States.

Authors:  Girishanthy Krishnarajah; Kitaw Demissie; Patrick Lefebvre; Sunanda Gaur; Mei Sheng Duh
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.